26388 | 2 Lorem Ipsum is simply dummy text of the | testuser | 02/01/2014 1:07:55 AM |
26387 | 1 Lorem Ipsum is simply dummy text of the | testuser | 02/01/2014 1:07:48 AM |
26386 | thats cool | testuser | 01/31/2014 3:27:17 PM |
26385 | testtt | testuser | 01/31/2014 3:27:04 PM |
26384 | testing | testuser | 01/31/2014 3:26:52 PM |
26382 | If we see half of the volume we saw yesterday, we | Spiceman | 01/31/2014 6:22:10 AM |
26381 | Hi | testuser | 01/23/2014 9:44:55 AM |
26380 | public reply | saurabh | 01/23/2014 8:21:30 AM |
26379 | test post new | saurabh | 01/23/2014 8:20:29 AM |
26378 | asdasdasd // >> | itest | 01/22/2014 1:58:14 AM |
26377 | bolded text | itest | 01/22/2014 1:55:40 AM |
26376 | jbjkkbjbkjbk // >> | itest | 01/22/2014 1:52:00 AM |
26373 | test | testuser | 01/21/2014 9:02:37 PM |
26372 | hi | testuser | 01/17/2014 5:58:57 AM |
26371 | testingnggn | testuser | 01/17/2014 5:58:30 AM |
26366 | test post | itest | 01/17/2014 2:49:35 AM |
26365 | test Post test post | itest | 01/17/2014 12:20:53 AM |
26364 | test Post test post | itest | 01/17/2014 12:20:37 AM |
26362 | test | testuser | 01/16/2014 6:17:56 PM |
26361 | testt | testuser | 01/16/2014 6:17:45 PM |
26360 | Test | testuser | 01/16/2014 11:31:58 AM |
26359 | test reply | itest | 01/16/2014 10:20:29 AM |
26358 | test post | itest | 01/16/2014 10:20:02 AM |
26356 | Test | testuser | 01/16/2014 8:33:50 AM |
26355 | testing | itest | 01/07/2014 4:47:08 AM |
26354 | hello new post | itest | 01/06/2014 9:13:46 AM |
26353 | zxcZXcZXc | itest | 01/06/2014 9:12:58 AM |
26352 | dsfsadfasdasdf | itest | 01/06/2014 9:10:41 AM |
26351 | test post | itest | 01/06/2014 8:05:12 AM |
26350 | test post by itest | itest | 01/03/2014 6:35:57 AM |
26349 | tttt | Pipa | 12/31/2013 1:57:55 PM |
26347 | Public reply from itest | itest | 12/31/2013 8:09:01 AM |
26346 | New Post by itest | itest | 12/31/2013 8:08:35 AM |
26345 | New Post By I test | itest | 12/31/2013 7:16:53 AM |
26344 | test test test for the New | testuser | 12/30/2013 6:02:03 PM |
26343 | Happy New year to you! | fitzkarz | 12/30/2013 8:38:50 AM |
26342 | hey guys happy new year | itest | 12/30/2013 8:22:38 AM |
26341 | hello guys whats up | itest | 12/30/2013 8:18:07 AM |
26340 | Reply from itest as public | itest | 12/27/2013 8:26:09 AM |
26339 | test post again | itest | 12/27/2013 8:25:41 AM |
26338 | tes post by test gt | testgt | 12/27/2013 2:44:38 AM |
26337 | test post by itest | itest | 12/27/2013 2:43:06 AM |
26336 | testing | testuser | 12/26/2013 4:42:13 PM |
26335 | pot title post | itest | 12/26/2013 6:15:27 AM |
26334 | public reply from itest | itest | 12/20/2013 7:39:47 AM |
26333 | test | itest | 12/20/2013 7:39:27 AM |
26332 | test post by itest | itest | 12/20/2013 7:38:05 AM |
26330 | New post Again | saurabh | 12/20/2013 7:29:19 AM |
26328 | New Posted created by Saurabh | saurabh | 12/20/2013 7:07:26 AM |
26327 | ipr post | saurabh | 12/20/2013 6:55:51 AM |
Recent Articles
- Insights on Trump Administration's Week 33: Key Developments
- TCL Unveils Innovative Technology at IFA, Celebrates Olympic Spirit
- A Recap of Week 33 under Trump's Leadership and Policies
- BioMarin Shares Exciting New PALYNZIQ Data at Global Metabolism Event
- Revolutionary Display and Sound Technologies from Hisense
- Changhong Unveils Innovative Panda-Inspired Tech at IFA
- Roblox Corporation Faces Legal Scrutiny Amid Allegations
- SuperX AI Faces Scrutiny Amid Allegations of Misrepresentation
- Investors Urged to Act: Replimune Class Action Insight
- Charter Communications Investors: Join the Class Action Today
- Exploring the Digital Health Market: Growth and Innovations Ahead
- Understanding the LifeMD Class Action Lawsuit and What It Means
- Pomerantz Law Firm Investigates Potential Securities Fraud Claims
- Exploring the Growth of the Virtual Production Market by 2030
- Understanding the Securities Investigation of Six Flags Corp
- Novo Nordisk A/S Investors Urged to Act Before Deadline
- Critical Investor Alert: Novo Nordisk Claims Under Review
- TCL Mobile's Breakthrough in Eye-Care Display Technology
- Growing Opportunities in Antibody Discovery Market
- Investors of PubMatic, Inc. Urged to Join Class Action Lawsuit
- Investigation into EHang Holdings: What Investors Need to Know
- Pomerantz Firm Investigates NeoGenomics Investor Claims
- Investor Insights: Lineage, Inc. Faces Scrutiny Over Securities
- Investigation of Marex Group PLC Raises Significant Concerns
- Pomerantz Law Firm Investigates Valneva SE for Investors
- Investigation Into Molina Healthcare: Understanding Investor Concerns
- Tesla Faces Class Action as Stock Faces Increased Scrutiny
- Concerns Rise as Axogen, Inc. Faces Legal Investigations
- Exelixis, Inc. Faces Investigation: What Investors Need to Know
- James Hardie Industries Faces Investigation Over Financial Decline
- Tronox Holdings Faces Class Action Amid Sales Decline Concerns
- LifeMD, Inc. Investors Urged to Join Class Action Against Company
- Investors Raise Concerns about Spirit Aviation Holdings, Inc.
- Profiting from Opinions: Mark Cuban and Dogecoin Insights
- Understanding the Dow Inc. Class Action Lawsuit Opportunities
- MAGEASY Expands Global Reach with Launch at IFA 2025
- Exploring the Growth of the Sensor Patch Market through 2030
- Urgent Investor Alert: Insights on Biohaven Claims
- Deadline Nears for Unicycive Therapeutics Investor Claims
- Investigation into Centene Corporation: Important Update for Investors
- Exploring Insights on the Brown Fox and Its Journey
- Urgent Notice for Alto Neuroscience Investors on Claims Investigation
- Halper Sadeh LLC Focuses on Shareholder Rights for CCRD, SCS, RGLD
- Shareholder Rights Investigation on Major Corporate Deals
- Investigation Launched on Behalf of RxSight Investors
- Reworld Holding Corporation's Tender Offer Results and Insights
- Investors Urged to Act: Potential Claims Against PubMatic
- Flywire Corporation's Investors Urged to Act Before Deadline
- Investors Take Note: Deadline Approaching for LifeMD Claims
- Investigation Announced for Sable Offshore Investors: Act Now